EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Protein kinase C and endothelial dysfunction in select vascular diseases

Shawn Kant, Jun Feng

Frontiers in Cardiovascular Medicine · 25.08.2025 · 12

DOI: 10.3389/fcvm.2025.1618343 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Frontiers in Cardiovascular Medicine, online erschienen am 25.08.2025. Verfasst von Shawn Kant und 1 weiteren Autor:innen. Beteiligte Einrichtung: Cardiothoracic Surgery Research Laboratory, Department of Medicine, Rhode Island Hospital, Brown University Health, Providence, RI, United States. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 160 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Protein kinases have crucial roles in intracellular signal transduction pathways that affect a wide range of biochemical processes, including apoptosis, metabolism, proliferation, and protein synthesis. Vascular endothelial cells are important regulators of vasomotor tone, tissue/organ perfusion, and inflammation. Since its discovery in the late 1970s, a growing body of literature implicates protein kinase C (PKC) in pathways involving angiogenesis, endothelial permeability, microvascular tone, and endothelial activation. Hence the objective of this review, to characterize the role of PKC in vascular endothelial cells. After discussing the basic principles of PKC structure and function, the focus shifts to abnormal PKC activity driving endothelial dysfunction in three major pathologies whose hallmark is significant vascular disease: diabetes mellitus, hypoxia/ischemia-reperfusion injury, and hypertension. Themes addressed include endothelial cell cycle derangement, endothelial oxidative stress, endothelial activation/inflammation, and impaired endothelial barrier integrity. Achieving a comprehensive understanding of endothelial cell-PKC pathophysiology may lead to development of new therapeutic targets for mitigating morbidity and mortality in these disease states.

Schlagwörter

Stichwörter der Autor:innen

PKCdiabetesendothelial cellhypertensionischemia-reperfusionvascular function

Autor:innen und Institutionen

  • Cardiothoracic Surgery Research Laboratory, Department of Medicine, Rhode Island Hospital, Brown University Health, Providence, RI, United States.
  • Department of Surgery, Heart Institute, Morsani College of Medicine, University of South Florida, Tampa, FL, United States.

Zitieren

APA

Kant, S., & Feng, J. (2025). Protein kinase C and endothelial dysfunction in select vascular diseases. Frontiers in Cardiovascular Medicine, 12. https://doi.org/10.3389/fcvm.2025.1618343

Vancouver

Kant S, Feng J. Protein kinase C and endothelial dysfunction in select vascular diseases. Frontiers in Cardiovascular Medicine. 2025;12. doi:10.3389/fcvm.2025.1618343

BibTeX
@article{Kant2025,
  author = {Kant, Shawn and Feng, Jun},
  title = {Protein kinase C and endothelial dysfunction in select vascular diseases},
  journal = {Frontiers in Cardiovascular Medicine},
  year = {2025},
  volume = {12},
  doi = {10.3389/fcvm.2025.1618343}
}
Kostenlos starten →